What is CRSP's current stock price?

As of now, CRSP is trading at $73.53, with a daily change of -0.59%.

What are the risks associated with CRSP stock?

CRSP Key risk is its Extreme Risk Level, .

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Earnings Calendar Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

CRSP Stock Analysis & IQ Rating | CRISPR Therapeutics

CRSP

CRISPR Therapeutics

$73.53

-$0.44 | -0.59%

Create Alerts

Overview

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Earnings

Headlines

52W High

$ 78.48

MKT CAP

$ 6.66B

52W Low

$ 30.04

VOL

$ 111.53K

P/E Ratio

N/A

AVG VOL

$ 2.73M

RSI

60.54

TREND

Uptrend

CRSP Stock IQ

Login to see CRISPR Therapeutics (CRSP) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

CRSP Target Price

Login to display

Strengths

CRSP Rewards

Earnings are forecast to grow

CRSP Rewards

Upgraded on attractively valued

CRSP Rewards

Outperform the market

Chart

$61.05 (+20.44%)

$59.02 (+24.58%)

$36.29 (+102.62%)

$50.59 (+45.34%)

1year

6month

3month

1month

CRSP Risk Level

CRSP has Extreme Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

Risks Indicators

Beta greater than 1.0

High volatilty

LOW

HIGH

CRSP Analysts Opinion

CRSP overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

CRSP Analysts Opinion

CRSP Analysts opinion is positive and also has improved from the past 3 months

CRSP Street Consensus

Analysts perspectives on the stock desirability, trend direction, and growth potential.

64%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

25%

67%

CRSP Street Opinion

CRSP Street view is bullish and have positive views on the near-term outlook

CRSP Performance Sentiment

Sentiments overview associated with CRSP events and the stock performance.

64%

29%

Positive

Negative

9 out of 14
events present

4 out of 14
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$69.15

Resistance
Price

$52.82

Current Price Range

$76.78

Show methods +

Linked to CRSP

IQ

Close Price

Change

VCEL

2.00

35.92

-0.26%

IBRX

3.50

2.44

-0.41%

CLDI

N/A

1.55

-3.13%

BNTX

2.15

106.30

-1.53%

AMGN

4.05

299.62

-1.22%

CRSP Latest Analysis +

B of A Securities Maintains CRISPR Therapeutics (CRSP) Buy Recommendation. Fintel reports that on October 17 2025 B of A Securities maintained coverage of CRISPR Therapeutics (NasdaqGM:CRSP) with a Buy recommendation. Analyst Price Forecast Suggests 18.84% Upside

Fri Oct 17, 2025

$69.15 | +1.05%

Rating

2 Soaring Cathie Wood Stocks to Buy and Hold. Key PointsCRISPR Therapeutics and Spotify Technologies have crushed the market year to date.

Fri Oct 17, 2025

$69.15 | +1.05%

Potential

New to Growth Stocks? Heres 1 Every Investor Should Have on Their Radar.. Key PointsCRISPR Therapeutics has an approved gene-editing therapy Casgevy which can be a game changer for patients who need it.

Thu Oct 16, 2025

$68.43 | -4.72%

Activity

CRISPR Therapeutics files for $600M stock offering.

Thu Oct 16, 2025

$68.43 | -4.72%

Activity

CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: What You Should Know. In the most recent trading session CRISPR Therapeutics AG (CRSP) closed at $68.29 indicating a -6.54% shift from the previous trading day.

Mon Oct 13, 2025

$68.29 | -6.54%

Momentum

CRISPR Therapeutics (CRSP) Surges 8.7%: Is This an Indication of Further Gains?. CRISPR Therapeutics (CRSP) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Thu Oct 9, 2025

$74.92 | -2.42%

Momentum

Editas Medicine Announces EDIT-401 Oral Presentation at the European Society of Gene and Cell Therapy (ESGCT) 32nd Annual Congress and Participation in Upcoming Investor Conferences. CAMBRIDGE Mass. Oct. 06 2025 (GLOBE NEWSWIRE) -- Editas Medicine Inc. (NASDAQ:) a pioneering gene editing company focused on developing transformative medicines for serious diseases today announced an oral presentation at the upcoming European Society of Gene and Cell Therapy (ESGCT) Congress to be held October 7-10

Mon Oct 6, 2025

$70.19 | +3.62%

Activity

CRISPR Therapeutics AG (CRSP) Stock Falls Amid Market Uptick: What Investors Need to Know. CRISPR Therapeutics AG (CRSP) reached $67.74 at the closing of the latest trading day reflecting a -6.98% change compared to its last close.

Fri Oct 3, 2025

$67.74 | -6.98%

Momentum

Looking At CRISPR Therapeuticss Recent Unusual Options Activity. High-rolling investors have positioned themselves bearish on CRISPR Therapeutics (NASDAQ:CRSP) and it'.s important for retail traders to take note.\This activity came to our attention today through Benzinga'.s tracking of publicly available options data. The identities of these investors are uncertain but such a significant move in CRSP often signals that someone has privileged information.Today Benzinga'.s options scan

Thu Oct 2, 2025

$72.82 | +10.07%

Momentum

Potential

H.C. Wainwright Reiterates Buy Rating on CRISPR Therapeutics AG (CRSP) Stock. CRISPR Therapeutics AG (NASDAQ:CRSP) is one of the Unstoppable Stocks to Buy and Hold for the Next 5 Years. On September 23 analyst Mitchell Kapoor from H.C. Wainwright reiterated a Buy rating on the companys stock while keeping the price objective at $80.00. As per the firm the current price target does not yet include any contribution from [….]

Wed Oct 1, 2025

$66.16 | +2.08%

Activity

Rating

FAQ About CRSP Stock Insights

What is CRSP current stock price?

What are CRSP stock strengths?

What risks are associated with CRSP stock?

When is CRSP next earnings report?

What is CRSP market cap and volume?

What is CRSP's current Stock IQ?

Should I buy CRSP stock right now?

Is CRSP a Strong Buy right now?

What does a 'Strong Buy' rating mean for CRSP?

What does a 'Strong Sell' rating mean for CRSP?

What factors influence CRSP's Stock IQ?

Explore our CRSP Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored CRSP Stock Strategies
Effective Risk Management

FIND US ON

Receive our CRSP Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

CRSP

CRISPR Therapeutics

Current Price

$73.53

-$0.44 | -0.59%

52W High

$ 78.48

MKT CAP

$ 6.66B

52W Low

$ 30.04

VOL

$ 111.53K

P/E Ratio

N/A

AVG VOL

$ 2.73M

RSI

60.54

TREND

Uptrend

Create Alerts

Overview

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Earnings

Target Price

Login to display

Not Enough Information

Stock Insights

Strengths

CRSP Rewards

Earnings are forecast to grow

CRSP Rewards

Upgraded on attractively valued

CRSP Rewards

Outperform the market

Linked to CRSP

Symbol

IQ

Close

Change

VCEL

2.00

35.92

-0.26%

IBRX

3.50

2.44

-0.41%

CLDI

N/A

1.55

-3.13%

BNTX

2.15

106.30

-1.53%

AMGN

4.05

299.62

-1.22%

CRSP Stock IQ

Login to unlock CRISPR Therapeutics (CRSP) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

Chart

$61.05 (+20.44%)

$59.02 (+24.58%)

$36.29 (+102.62%)

$50.59 (+45.34%)

1year

6month

3month

1month

CRSP Analysts Opinion

CRSP Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

CRSP Analysts Opinion

CRSP Analysts opinion is positive and also has improved from the past 3 months

CRSP Street Consensus

Analysts perspectives on the stock desirability, trend direction, and growth potential.

64%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

25%

67%

CRSP Street Opinion

CRSP Street view is bullish and have positive views on the near-term outlook

CRSP Risk Level

CRSP has Extreme Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

Risks Indicators

Beta greater than 1.0

High volatilty

LOW

HIGH

CRSP Performance Sentiment

Sentiments overview associated with CRSP events and the stock performance.

64%

29%

Positive

Negative

9 out of 14
events present

4 out of 14
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$69.15

Resistance
Price

$52.82

Current Price Range

$76.78

Show methods +

CRSP Latest Analysis

B of A Securities Maintains CRISPR Therapeutics (CRSP) Buy Recommendation. Fintel reports that on October 17 2025 B of A Securities maintained coverage of CRISPR Therapeutics (NasdaqGM:CRSP) with a Buy recommendation. Analyst Price Forecast Suggests 18.84% Upside

Fri Oct 17, 2025

$69.15 | +1.05%

Rating

2 Soaring Cathie Wood Stocks to Buy and Hold. Key PointsCRISPR Therapeutics and Spotify Technologies have crushed the market year to date.

Fri Oct 17, 2025

$69.15 | +1.05%

Potential

New to Growth Stocks? Heres 1 Every Investor Should Have on Their Radar.. Key PointsCRISPR Therapeutics has an approved gene-editing therapy Casgevy which can be a game changer for patients who need it.

Thu Oct 16, 2025

$68.43 | -4.72%

Activity

CRISPR Therapeutics files for $600M stock offering.

Thu Oct 16, 2025

$68.43 | -4.72%

Activity

CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: What You Should Know. In the most recent trading session CRISPR Therapeutics AG (CRSP) closed at $68.29 indicating a -6.54% shift from the previous trading day.

Mon Oct 13, 2025

$68.29 | -6.54%

Momentum

CRISPR Therapeutics (CRSP) Surges 8.7%: Is This an Indication of Further Gains?. CRISPR Therapeutics (CRSP) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Thu Oct 9, 2025

$74.92 | -2.42%

Momentum

Editas Medicine Announces EDIT-401 Oral Presentation at the European Society of Gene and Cell Therapy (ESGCT) 32nd Annual Congress and Participation in Upcoming Investor Conferences. CAMBRIDGE Mass. Oct. 06 2025 (GLOBE NEWSWIRE) -- Editas Medicine Inc. (NASDAQ:) a pioneering gene editing company focused on developing transformative medicines for serious diseases today announced an oral presentation at the upcoming European Society of Gene and Cell Therapy (ESGCT) Congress to be held October 7-10

Mon Oct 6, 2025

$70.19 | +3.62%

Activity

CRISPR Therapeutics AG (CRSP) Stock Falls Amid Market Uptick: What Investors Need to Know. CRISPR Therapeutics AG (CRSP) reached $67.74 at the closing of the latest trading day reflecting a -6.98% change compared to its last close.

Fri Oct 3, 2025

$67.74 | -6.98%

Momentum

Looking At CRISPR Therapeuticss Recent Unusual Options Activity. High-rolling investors have positioned themselves bearish on CRISPR Therapeutics (NASDAQ:CRSP) and it'.s important for retail traders to take note.\This activity came to our attention today through Benzinga'.s tracking of publicly available options data. The identities of these investors are uncertain but such a significant move in CRSP often signals that someone has privileged information.Today Benzinga'.s options scan

Thu Oct 2, 2025

$72.82 | +10.07%

Momentum

Potential

H.C. Wainwright Reiterates Buy Rating on CRISPR Therapeutics AG (CRSP) Stock. CRISPR Therapeutics AG (NASDAQ:CRSP) is one of the Unstoppable Stocks to Buy and Hold for the Next 5 Years. On September 23 analyst Mitchell Kapoor from H.C. Wainwright reiterated a Buy rating on the companys stock while keeping the price objective at $80.00. As per the firm the current price target does not yet include any contribution from [….]

Wed Oct 1, 2025

$66.16 | +2.08%

Activity

Rating

Discover CRSP Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of CRSP. We're here to help you make informed investment decisions today.

FIND US ON

Receive our CRSP Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

CRSP Stock trends

CRSP Stock performance

CRSP Stock analysis

CRSP investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing CRSP

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing CRSP

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

CRSP Stock Analysis & IQ Rating | CRISPR Therapeutics

CRSP Stock IQ

CRSP Target Price

CRSP Risk Level

CRSP Analysts Opinion

CRSP Street Consensus

CRSP Performance Sentiment

Technical Price Levels

Explore our CRSP Stock insights

Receive our CRSP Daily Alerts

CRSP Stock IQ

CRSP Street Consensus

CRSP Risk Level

Technical Price Levels

Discover CRSP Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of CRSP. We're here to help you make informed investment decisions today.

Receive our CRSP Daily Alerts

CRSP Runner Alarm